The increase in the glycolytic phenotype of CLL cells in LNs is BCR-dependent, although a specific subpopulation of CLL cells with a del17p (often correlated with TP53 mutation) appears to spontaneous display this metabolic characteristic [23]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.